Oculis appoints Björn Tackenberg as chief scientific officer

OCS•2026-11-02

Oculis appointed Björn Tackenberg chief scientific officer. He will lead global scientific strategy, prioritizing Privosegtor's PIONEER program and potential applications in acute multiple sclerosis relapses.

Oculis appoints Björn Tackenberg as chief scientific officer

1. Leadership appointments

Related News

Japan's Nikkei ends lower as Kioxia tanks, Tokyo Electron rises on strong outlook

Colgate-Palmolive target price raised to $105 from $104

Kosmos Energy Q3 revenue falls short of estimates

Bancorp Inc: KBW cuts target price to $56 from $65

AngloGold Ashanti gets buy rating from TD Cowen with $123 target price